The DREAM RA Responder Challenge introduced a novel approach to predicting anti-TNF treatment response by proposing an optimal model that incorporates Gaussian Process Regression (GPR) and integrates demographic, clinical, and genetic markers. The gene discussed is TNF; the disease is rheumatoid arthritis.